000127558 001__ 127558
000127558 005__ 20241125101142.0
000127558 0247_ $$2doi$$a10.3390/jcm12165408
000127558 0248_ $$2sideral$$a134542
000127558 037__ $$aART-2023-134542
000127558 041__ $$aeng
000127558 100__ $$0(orcid)0000-0002-5618-7519$$aDe Gregorio, Miguel Ángel$$uUniversidad de Zaragoza
000127558 245__ $$aA comparative study of a small series of patients (50 patients) with pelvic varicose veins treated with plugs alone or plugs and polidocanol
000127558 260__ $$c2023
000127558 5060_ $$aAccess copy available to the general public$$fUnrestricted
000127558 5203_ $$aLevel of Evidence: Level 2. Purpose: To compare the safety and efficacy of vascular plug (VP) and vascular plug and polidocanol foam (VPPF) treatments for embolization in pelvic congestion syndrome (PCS). Materials and methods: A comparative, prospective, two-center study enrolled 50 women with PCS from January 2019 to January 2020. The patients were divided into two groups, and embolization was performed with VP (n = 25) and VPPF (n = 25) treatments. The mean age of the patients was 45.6 years ± 6.9. Three clinical parameters were assessed: abdominal pain, dyspareunia, and lower limb pain. The primary outcome (clinical success at 1 yr using a VAS), number of devices, procedure and fluoroscopy times, radiation doses, costs, and complications were compared. The participants were followed-up at 1, 3, 6, and 12 months. Results: At the 1-year follow-up, clinical success did not significantly differ between the two groups (VP vs. VPPF) regarding the improvement of the symptoms analyzed (pelvic pain, dyspareunia, lower extremity pain, and other symptoms (p < 0.05)). The mean number of devices per case was 4 ± 1.1 for the VP group and 2 ± 0.31 for the VPPF group (p < 0.001). No major complications were recorded in either group. The VPPF group had a significantly longer fluoroscopy time (42.8 min ± 14.2 vs. 25.4 min ± 7) and longer radiation dose (VPPF air kerma 839.4 ± 513 vs. VP air kerma 658.4 mGy ± 355 (all p < 0.001)). Conclusions: Embolization for PCS resulted in pain relief in 90% of patients; the use of polidocanol did not demonstrate changes in the clinical outcome. The use of a VP alone was associated with decreased fluoroscopy time and radiation dose.
000127558 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000127558 590__ $$a3.0$$b2023
000127558 592__ $$a0.882$$b2023
000127558 591__ $$aMEDICINE, GENERAL & INTERNAL$$b59 / 329 = 0.179$$c2023$$dQ1$$eT1
000127558 593__ $$aMedicine (miscellaneous)$$c2023$$dQ1
000127558 594__ $$a5.7$$b2023
000127558 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000127558 700__ $$aYamamoto-Ramos, Masao
000127558 700__ $$aFredes, Arturo
000127558 700__ $$0(orcid)0000-0002-8880-6580$$aSerrano-Casorran, Carolina$$uUniversidad de Zaragoza
000127558 700__ $$aSierre, Sergio
000127558 700__ $$aCiampi-Dopazo, Juan José
000127558 700__ $$aMéndez, Santiago
000127558 700__ $$aAbadal, Jose Maria
000127558 700__ $$aUrtiaga, Ignacio
000127558 700__ $$0(orcid)0000-0001-6178-9891$$aBonastre, Cristina$$uUniversidad de Zaragoza
000127558 700__ $$aRodríguez, Jose
000127558 700__ $$aUrbano, Jose
000127558 700__ $$0(orcid)0000-0002-0113-5121$$aGuirola, José Andrés$$uUniversidad de Zaragoza
000127558 7102_ $$11011$$2770$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Radiol. y Medicina Física
000127558 7102_ $$11009$$2617$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Medicina y Cirugía Animal
000127558 773__ $$g12, 16 (2023), 5408 [12 pp.]$$pJ. clin.med.$$tJournal of Clinical Medicine$$x2077-0383
000127558 8564_ $$s1345674$$uhttps://zaguan.unizar.es/record/127558/files/texto_completo.pdf$$yVersión publicada
000127558 8564_ $$s2665231$$uhttps://zaguan.unizar.es/record/127558/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000127558 909CO $$ooai:zaguan.unizar.es:127558$$particulos$$pdriver
000127558 951__ $$a2024-11-22-12:02:59
000127558 980__ $$aARTICLE